A Study of Minirin Melt in Patients With Nocturia

Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01222598

Enrollment

588

Registered

2010-10-18

Start date

2008-09-30

Completion date

2011-03-31

Last updated

2012-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocturia

Brief summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 64 Years

Healthy volunteers

Inclusion criteria

* patients suffering from Nocturia

Exclusion criteria

* habitual or psychogenic polydipsia * known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics * moderate and severe renal insufficiency * know hyponatremia * syndrome of inappropriate ADH secretion

Design outcomes

Primary

Measure	Time frame
Number of participants with adverse events	12 months

Secondary

Measure	Time frame
Number of participants with nocturnal voiding	12 months
Number of participants with adverse events	12 months

Countries

Czechia

Outcome results